House Health Reform Bill Increases Drug Rebates, Drops Part D Donut Hole
The House health care reform bill asks pharmaceutical manufacturers to pay their share of the cost of expanding health care coverage by paying higher rebates on more drugs
You may also be interested in...
House health reform bill includes PhRMA's offer of 50 percent discounts on drugs for Medicare beneficiaries in the Part D donut hole, but also contains Medicaid-level rebates on drugs used by dual-eligibles.
Seventy House Democrats support PhRMA's discount proposal in lieu of phasing out the Part D coverage gap with funds from new rebates collected on drugs for dual-eligibles.
Rebates for Medicare/Medicaid dual eligible enrollees would generate $63 billion over 10 years, Congressional Budget Office estimates; phase-out of donut hole would cost only $47 billion, but most expensive years come after 10 year budget window.